New study investigates whether chemoradiation before surgery reduces cancer cells in the blood

NCT ID NCT07194616

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This clinical trial is looking at how chemoradiation given before surgery affects circulating tumor cells (CTCs) in patients with stage II-III rectal cancer. CTCs are cancer cells that travel in the blood and may indicate how likely the cancer is to spread. The study will compare two groups: one that gets chemoradiation followed by surgery, and another that has surgery alone. By tracking CTCs over time, researchers hope to learn more about which treatment approach might be better at controlling the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

fluoropyrimidine-based chemotherapy and radiotherapy

What this could lead to

If successful, this study could help doctors understand whether chemoradiation before surgery reduces the spread of cancer cells in the bloodstream, potentially guiding better treatment decisions for rectal cancer.

What could go wrong

This is an early-stage observational trial focused on a biomarker, not a direct treatment outcome. The results may not lead to immediate changes in patient care, and the sample size is relatively small.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neoplastic Cells, Circulating rectal cancer rectal neoplasm rectum adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Municipal Hospital Ostrava - Fifejdy

    RECRUITING

    Ostrava, 728 80, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Palacky University Olomouc, Faculty of Medicine

    RECRUITING

    Olomouc, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University Hospital Olomouc

    RECRUITING

    Olomouc, 779 00, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University Hospital Ostrava

    RECRUITING

    Ostrava, 70852, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact